Editorial note for the desk: The source payload supplied for this rewrite contains only the headline — “China Proposes Major Reforms to Cosmetic Registration and Filing Rules — Regulatory News,” attributed to CIRS Group — and a redirect link. No article body, dates, regulatory document numbers, NMPA references, filing categories, transition timelines, company statements or quoted spokespersons were transmitted.

Under the INCI File editorial rules in force for this assignment, the following items are explicitly forbidden without source support:

• Any specific NMPA order number, draft regulation reference, or CSAR/NMPB chapter citation
• Any filing-fee figure, transition window (e.g. “by 1 January 2025”), or implementation date
• Any direct quotation attributed to a CIRS analyst, NMPA official, brand or industry association
• Any INCI ingredient, concentration, or test method named in connection with the reform
• Any analytical claim about impact on formulators, distributors, e-commerce operators or testing labs

Producing a 520–1,000-word piece to the CosmeticsDesign / Global Cosmetic Industry standard under those constraints would require fabricating numbers, dates, and quotes — a direct breach of the brief’s “do not add information absent from the source” and “never invent numbers or quotes” clauses, and incompatible with the publication’s regulatory reporting standards.

What the desk needs to clear the rewrite:

1. The full text of the CIRS Group regulatory alert, or a direct link to the underlying NMPA notice / draft measure
2. The publication date and the document reference number China’s National Medical Products Administration assigned to the consultation
3. Any named spokesperson from CIRS, the China Association of Fragrance Flavor and Cosmetic Industries (CAFFCI), or a brand filing under the new framework
4. The specific articles of the Cosmetic Supervision and Administration Regulation (CSAR, 2021) or the Cosmetic Registration and Filing Measures (2021) that the proposal amends
5. The consultation comment deadline, if open

Once the body text is supplied, the rewrite can be delivered to specification: opening sentence anchored on the hardest fact (regulation number, deadline, or filing-volume figure), one to two direct quotations, question-form H2 subheads, sub-60-word paragraphs, and a forward-looking closer on the next regulatory milestone to watch. The piece will be built for the audience that needs it most — R&D leads re-validating formulas, regulatory affairs teams rebuilding submission packs, and brand owners timing China launches against the new effective date.